Free Trial

INVO Fertility (IVF) Competitors

INVO Fertility logo
$0.84 +0.07 (+9.01%)
As of 04:00 PM Eastern

IVF vs. BTCY, OSRH, SINT, CHEK, MHUA, POAI, XAIR, INBS, FEMY, and LYRA

Should you be buying INVO Fertility stock or one of its competitors? The main competitors of INVO Fertility include Biotricity (BTCY), OSR (OSRH), Sintx Technologies (SINT), Check-Cap (CHEK), Meihua International Medical Technologies (MHUA), Predictive Oncology (POAI), Beyond Air (XAIR), Intelligent Bio Solutions (INBS), Femasys (FEMY), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry.

INVO Fertility vs. Its Competitors

INVO Fertility (NASDAQ:IVF) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 0.6% of INVO Fertility shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Biotricity has a net margin of -80.42% compared to INVO Fertility's net margin of -422.11%.

Company Net Margins Return on Equity Return on Assets
INVO Fertility-422.11% N/A -90.34%
Biotricity -80.42%N/A -188.47%

INVO Fertility has a beta of 1.99, meaning that its share price is 99% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INVO Fertility
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Biotricity
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

INVO Fertility has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INVO Fertility$6.53M0.56-$9.10M-$93.14-0.01
Biotricity$12.06M1.22-$14.09M-$0.21-2.62

In the previous week, INVO Fertility had 1 more articles in the media than Biotricity. MarketBeat recorded 1 mentions for INVO Fertility and 0 mentions for Biotricity. INVO Fertility's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.

Company Overall Sentiment
INVO Fertility Neutral
Biotricity Neutral

Summary

INVO Fertility and Biotricity tied by winning 6 of the 12 factors compared between the two stocks.

Get INVO Fertility News Delivered to You Automatically

Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IVF vs. The Competition

MetricINVO FertilitySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3.35M$75.67M$6.05B$10.54B
Dividend YieldN/AN/A5.68%4.67%
P/E Ratio-0.0110.9276.3926.55
Price / Sales0.5627.62582.40237.78
Price / CashN/A18.4137.8961.20
Price / Book-0.0116.6312.546.48
Net Income-$9.10M-$26.39M$3.30B$277.02M
7 Day Performance-2.44%2.14%28,086.98%1.84%
1 Month Performance-9.43%8.04%30,478.96%8.29%
1 Year Performance-96.56%68.15%35,729.70%36.66%

INVO Fertility Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IVF
INVO Fertility
0.1027 of 5 stars
$0.84
+9.0%
N/A-96.9%$3.35M$6.53M-0.0110Positive News
Gap Down
BTCY
Biotricity
N/A$0.57
-6.8%
N/A+157.6%$14.27M$12.06M-0.5340Gap Down
OSRH
OSR
N/A$0.65
-11.2%
N/AN/A$14.10MN/A0.00N/APositive News
Short Interest ↓
SINT
Sintx Technologies
2.548 of 5 stars
$4.88
+3.6%
$25.00
+412.3%
+29.6%$13.47M$2.89M-0.1040
CHEK
Check-Cap
N/A$2.24
-8.6%
N/A+74.4%$13.10MN/A-0.7580Short Interest ↑
Gap Down
MHUA
Meihua International Medical Technologies
0.6984 of 5 stars
$0.40
+2.1%
N/A-64.0%$12.77M$96.90M0.00620Short Interest ↑
POAI
Predictive Oncology
0.9744 of 5 stars
$1.16
-0.9%
N/A+16.8%$12.63M$1.62M-0.3830Stock Split
Short Interest ↓
XAIR
Beyond Air
4.1649 of 5 stars
$2.31
-1.7%
$11.00
+376.2%
-59.8%$12.08M$3.70M-0.1970
INBS
Intelligent Bio Solutions
1.3734 of 5 stars
$1.32
-1.9%
N/A-37.0%$11.99M$3.05M-0.6410Positive News
FEMY
Femasys
3.0849 of 5 stars
$0.34
-4.7%
$7.33
+2,029.3%
-66.5%$11.22M$1.63M-0.4030Gap Up
LYRA
Lyra Therapeutics
3.4782 of 5 stars
$6.64
+3.4%
$100.00
+1,406.0%
-48.8%$10.89M$1.53M-0.2350News Coverage
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:IVF) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners